US Patent Issued to Aurigene Oncology on Sept. 9 for "Bicyclic heterocyclyl derivatives as IRAK4 inhibitors" (Indian Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,193, issued on Sept. 9, was assigned to Aurigene Oncology Ltd. (Bangalore, India).

"Bicyclic heterocyclyl derivatives as IRAK4 inhibitors" was invented by Venkateshwar Rao Gummadi (Bangalore, India) and Susanta Samajdar (Bangalore, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bicyclic heterocyclyl kinase enzyme inhibitor compounds of formula (I), which are therapeutically useful as kinase inhibitors, particularly IRAK4 inhibitors.wherein A, Y, Z, X1, X2, X3, R1, R3, 'm', 'n' and 'p' have the meanings given in the specification and pharmaceutically acceptable salts or stereoisomers thereof that are useful in th...